Greenfield Savings Bank lowered its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 9.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,600 shares of the financial services provider’s stock after selling 275 shares during the period. Greenfield Savings Bank’s holdings in Aflac were worth $269,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in AFL. Darwin Wealth Management LLC bought a new stake in Aflac during the 3rd quarter worth approximately $34,000. Raelipskie Partnership bought a new stake in shares of Aflac in the 3rd quarter valued at $38,000. Covestor Ltd boosted its stake in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. Kennebec Savings Bank bought a new position in Aflac during the third quarter worth $45,000. Finally, Catalyst Capital Advisors LLC acquired a new position in Aflac during the third quarter worth $51,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Aflac Stock Up 1.5 %
Shares of Aflac stock opened at $102.52 on Tuesday. The firm has a market cap of $56.95 billion, a price-to-earnings ratio of 15.44, a PEG ratio of 2.09 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 1 year low of $75.07 and a 1 year high of $115.50. The company has a 50-day moving average of $106.59 and a 200 day moving average of $105.02.
Aflac Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be paid a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.26%. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. Aflac’s dividend payout ratio (DPR) is currently 34.94%.
Analyst Ratings Changes
AFL has been the topic of several research reports. JPMorgan Chase & Co. upped their price objective on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a report on Friday. Wells Fargo & Company increased their target price on shares of Aflac to $107.00 and gave the stock a “hold” rating in a research report on Tuesday, December 3rd. Piper Sandler raised their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Barclays raised their price objective on shares of Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a research report on Monday, January 6th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $102.29.
Get Our Latest Stock Report on AFL
Insider Transactions at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.90% of the company’s stock.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- About the Markup Calculator
- Analyst Upgrade Shows Over Double Bagger Potential for BigBear.ai
- Using the MarketBeat Stock Split Calculator
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Why Invest in High-Yield Dividend Stocks?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.